Topic: Cleviprex
Shares of The Medicines Compan (MDCO) hit a new 52-week high on Monday. The stock traded as high as $19.46 during mid-day trading and last traded...
Equities research analysts at Citigroup (NYSE: C) raised their price target on shares of The Medicines Compan (NASDAQ: MDCO) to $24.00 in a...
Posted on 10/03/11 at 11:00am by Eddie Staley . The Medicines Company (NASDAQ: MDCO ) announced today launch of a new twelve hour formulation for...
Equities research analysts at Argus lowered their price target on shares of The Medicines Compan (NASDAQ: MDCO) from $25.00 to $20.00 in a research...
Equities research analysts at Argus upgraded shares of The Medicines Compan (NASDAQ: MDCO) from a "hold" rating to a "buy" rating in a research...
The Medicines Compan (MDCO) announced its quarterly results on Wednesday. The company reported $0.45 earnings per share for the quarter, beating...
117-134 Link text Cleviprex is contraindicated in patients with allergies to soybeans, soy products, eggs, or egg products; defective lipid metabolism such as pathologic hyperlipemia (rare genetic disorders characterized by abnormal triglyceride metabolism), lipoid nephrosis, or acute pancreatitis if it is accompanied ...
FDA says Medicines Co. recalling intravenous hypertension drug that contains bits of steelFederal health regulators are warning doctors about 11 recalled lots of an intravenous hypertension drug made by the Medicines Co. that are contaminated with bits of steel.The Parsippany, N ...
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Their progress was monitored for the next six years of medical school, United Press International reported.. The scientists found that these proteins prevent most virus ...
PARSIPPANY, NJ--(Marketwire - November 12, 2009) - First reported interim data from the Evaluation of patients with acute hypertension and intracerebral hemorrhage with intravenous clevidipine treatment (ACCELERATE) trial were presented today at the Neurocritical Care Society (NCS) 2009 Annual Meeting, showing that Cleviprex ...